Search results
New COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 4 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
What should you do if you’re still testing positive for COVID-19 after day 10?
The Today Show via AOL· 4 days agoThe virus poses particularly serious risks for certain populations, including immunocompromised...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 7 hours agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN.com· 1 day agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 2 days agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 4 days agoAccording to the panel, vaccine manufacturers should design updated vaccines to target the JN.1...
Live updates: Fauci gives spirited defense to GOP claims of COVID cover-up
The Hill· 6 days agoRecorded earlier Anthony Fauci, the face of the federal response to the COVID-19 pandemic, is...
Is a Summer COVID Booster Worth It?
Verywell Health via Yahoo News· 4 days agoSome People May Benefit From a Summer Shot Anyway Here’s where things get slightly complicated. When the updated COVID vaccine was released last fall,...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 2 days agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say By...
Investing.com· 4 days agoCOVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say